Let it GLOW: Novel Proximity Inducing Modality for DNA Modification
DNA methyltransferases (MTases) can recognize specific DNA sequences and transfer a methyl group from the S-adenosyl-L-methionine (SAM) cofactor to a target nucleobase. This ability has been exploited for sequence-specific DNA labeling using synthetic SAM analogues (SMILing, mTAG).
However, both approaches (SMILing and mTAG) share following limitations:
๐ธ The SAM analogues are chemically reactive (labile aziridine rings or sulfonium centers)
๐ธ Labeling fails if the target nucleobase is already methylated by endogenous processes
๐๐ฒ๐ ๐ถ๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป
Chen et al. now report a novel proximity inducing S-adenosyl-L-methionine (SAM) mimetic modality that induces so-called “GLOW” (Guided Labeling Outside the natural site With MTases).
Instead of labeling at the target DNA nucleobase, this SAM mimetic modality uses the MTase only to induce proximity in a DNA-sequence-specific manner. This was achieved by replacing the unstable sulfonium/aziridine center with a stable amide moiety.
๐๐ผ๐ ๐ถ๐ ๐๐ผ๐ฟ๐ธ๐
The “GLOW modality” is tri-functional:
๐ธ SAM mimicking moiety for MTase binding (in dark blue – see the figure)
๐ธ Reactive warhead for covalent DNA attachment (green)
๐ธ Reporter group (azide or fluorophore) for detection (pink)
1) SAM mimetic moiety binds to MTase that simultaneously binds to a specific DNA sequence
2) The reactive “warhead” covalently modifies nucleobases adjacent to the recognition site.
๐ ๐ ๐ต๐ถ๐ด๐ต๐น๐ถ๐ด๐ต๐๐
โ
Six proximity-labeling SAM analogues synthesized with psoralen or chlorambucil warheads
โ
Chlorambucil variants with C-5′ modification outperformed psoralen variants
โ
Lead analogue 2d achieved ~70% labeling efficiency on a plasmid containing 12 target sites
โ
Sequence specificity confirmed by single-molecule fluorescence consensus mapping
โ
Fluorescent analogue 3b (the molecule in the figure below) enabled direct one-step DNA staining
๐ ๐ฒ๐๐ต๐๐น๐ฎ๐๐ถ๐ผ๐ป ๐ถ๐ป๐ฑ๐ฒ๐ฝ๐ฒ๐ป๐ฑ๐ฒ๐ป๐ฐ๐ฒ
On pre-methylated DNA, a conventional double-activated SAM analogue failed to label. GLOW molecule 3b retained sequence-specific labeling, confirming that this approach bypasses interference from endogenous methylation.
This is a conceptually distinct mode of MTase-directed DNA labeling with potential for genome mapping, epigenetic profiling, and single-molecule imaging in native genomic contexts.
๐ฆ๐ต๐ฎ๐ฟ๐ฒ ๐๐ผ๐๐ฟ ๐ผ๐ฝ๐ถ๐ป๐ถ๐ผ๐ป ๐ง
Do you think that this concept can be adopted for development of therapeutic proximity inducing modalities?
Full paper: https://lnkd.in/g7wnF8SF

